![](/wp-content/uploads/2022/10/October-25-222-Blast-Cover.png)
$599
Novartis and Adocia Q3 ’22 Earnings Updates
Two cardiometabolic-related news items have been observed; Novartis (press release; slides) hosted its Q3 ’22 earnings call; and Adocia issued a press release for its Q3 ’22 earnings, though it did not host an associated webcast. Below, FENIX provides highlights and insights from the respective new items.